Second edition

17.qxd 3/10/08 9:52 AM Page 563
Delalande S, de Seze J, Fauchais AL et al. Neurologic
manifestations in primary Sjögren syndrome: a study of 82
patients. Medicine 2004; 83:280–91.
Delaney P. Neurologic manifestations in sarcoidosis. Ann Intern
Med 1977; 87:336–45.
DeLorenze GN, Munger KL, Lennette ET et al. Epstein-Barr virus
and multiple sclerosis. Evidence of association from a
prospective study with long-term follow-up. Arch Neurol
2006; 63:839–44.
Devere TD, Trotter JL, Cross AH. Acute aphasia in multiple
sclerosis. Arch Neurol 2000; 57:1207–9.
Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological
findings in systemic lupus erythematosus: the role of
vasculitis, heart emboli, and thrombotic thrombocytopenic
purpura. Ann Neurol 1988; 23:380–4.
Diefendorf AR. Mental symptoms of acute chorea. J Nerv Ment Dis
1912; 39:161–72.
Doherty CP, Schlossmacher M, Torres N et al. Hashimoto’s
encephalopathy mimicking Creutzfeldt–Jakob disease: brain
biopsy findings. J Neurol Neurosurg Psychiatry 2002;
73:601–2.
Donaldson IM, Espiner EA. Disseminated lupus erythematosus
presenting as chorea gravidarum. Arch Neurol 1971;
25:240–4.
Douglas AC, Maloney AFJ. Sarcoidosis of the central nervous
system. J Neurol Neurosurg Psychiatry 1973; 36:1024–33.
Duffey P, Yee S, Rein IN et al. Hashimoto’s encephalopathy:
postmortem findings after fatal status epilepticus. Neurology
2003; 61:1124–6.
Durelli L, Verdun E, Barbero P et al. Every-other-day interferon
beta-1b versus once-weekly interferon beta-1a for multiple
sclerosis: results of a 2-year prospective randomized
multicentre study (INCOMIN). Lancet 2002; 359:1453–60.
Ebaugh FG. Neuropsychiatric aspects of chorea in children. JAMA
1926; 87:1083–8.
Ebers GC, Bulman DE, Sodovnik AD et al. Population-based studies
of multiple sclerosis in twins. N Engl J Med 1986;
315:1638–42.
Ebers GC, Sadovnik AD, Risch NJ. A genetic basis for familial
aggregation in multiple sclerosis. Canadian Collaborative
Study Group. Nature 1995; 377:150–1.
Ellis SG, Verity MA. Central nervous system involvement in
systemic lupus erythematosus: a review of neuropathologic
findings in 57 cases. Semin Arthritis Rheum 1979;
8:212–21.
Emery ES, Vieco PT. Sydenham chorea: magnetic resonance
imaging reveals permanent basal ganglia injury. Neurology
1997; 48:531–3.
European Study Group on Interferon Beta-1b in Secondary
Progressive MS. Placebo-controlled multicentre randomized
trial of interferon beta-1b in treatment of secondary
progressive multiple sclerosis. Lancet 1998; 352:1491–7.
Fassbender K, Schmidt R, Mofsner R et al. Mood disorders and
dysfunction of the hypothalamic-pituitary-adrenal axis in
multiple sclerosis. Arch Neurol 1998; 55:66–72.
Feinglass EJ, Arnett FC, Dorsch CA. Neuropsychiatric
manifestations of systemic lupus erythematosus: diagnosis,
References 563
clinical spectrum, and relationship to other features of the
disease. Medicine 1976; 55:323–39.
Feinstein AR, Spagnuola M. The clinical pattern of acute
rheumatic fever. Medicine 1962; 41:279–305.
Feinstein A, Feinstein K, Gray T et al. Prevalence and
neurobehavioral correlates of pathological laughing and crying
in multiple sclerosis. Arch Neurol 1997; 54:1116–21.
Feinstein A, Roy P, Lobaugh N et al. Structural brain abnormalities
in multiple sclerosis patients with major depression. Neurology
2004; 62:586–90.
Fermaglich J, Streib E, Auth T. Chorea associated with systemic
lupus erythematosus. Arch Neurol 1973; 28:276–7.
Fontaine B, Seilhean D, Tourbah A et al. Dementia in two
histologically confirmed cases of multiple sclerosis: one case
with isolated dementia and one case associated with
psychiatric symptoms. J Neurol Neurosurg Psychiatry 1994;
57:353–9.
Franklin GM, Heaton RK, Nelson LM et al. Correlations of
neuropsychological and MRI findings in chronic-progressive
multiple sclerosis. Neurology 1988; 38:1826–9.
Franklin GM, Nelson LM, Filley CM et al. Cognitive loss in multiple
sclerosis: case reports and review of the literature. Arch Neurol
1989; 46:162–7.
Futrell N, Schultz LR, Millikan C. Central nervous system disease
in patients with systemic lupus erythematosus. Neurology
1992; 42:1649–57.
Galluzzi S, Geroldi C, Zanetti O et al. Hashimoto’s encephalopathy
in the elderly: relationship to cognitive impairment. J Geriatr
Psychiatry Neurol 2002; 15:175–9.
Ganji S, Duncan MC, Frazier E. Sydenham’s chorea: clinical, CT
scan, and evoked potential studies. Clin Electroencephalogr
1988; 19:114–22.
Ganz VH, Gurland BJ, Deming WE et al. The study of the
psychiatric symptoms of systemic lupus erythematosus: a
biometric study. Psychosom Med 1972; 34:207–20.
Garvey MA, Snider LA, Leitman SF et al. Treatment of Sydenham’s
chorea with intravenous immunoglobulin, plasma exchange or
prednisone. J Child Neurol 2005; 20:424–9.
Gay W. Chorea insaniens. Brain 1889; 12:150–6.
Genel F, Arslanoglu S, Uran N et al. Sydenham’s chorea:
clinical findings and comparison of the efficacies of sodium
valproate and carbamazepine regimens. Brain Dev 2002;
24:73–6.
Gerstley JR, Wile SA, Falstein E et al. Chorea: is it a manifestation
of rheumatic fever? J Pediatr 1935; 6:42–50.
Geschwind DH, FitzPatrick M, Mischel PS et al. Sneddon’s
syndrome is a thrombotic vasculopathy: neuropathologic and
neuroradiologic evidence. Neurology 1995; 43:557–60.
Ghika-Schmid F, Ghika J, Regli F et al. Hashimoto’s myoclonic
encephalopathy: an underdiagnosed treatable condition? Mov
Disord 1996; 11:555–62.
Gibb WRG, Lees AJ. Tendency to late recurrence following
rheumatic chorea. Neurology 1989; 39:999.
Gibb WR, Lees AJ, Scadding JW. Persistent rheumatic chorea.
Neurology 1985; 35:101–2.
Glaser G, Pincus JH. Limbic encephalitis. J Nerv Ment Dis 1969;
149:59–67.